Loading insider details...
Latest Form 4 (Nov 4, 2026): Exercise/Conversion of 7,830 REGN shares, $2.95M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 7,830 | $2.95M |
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Dec 31, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 9,212 | $4.79M |
| Jan 3, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 3,338 | $1.38M |
| Sep 5, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift | 1,200 | n/a |
| May 6, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 2,000 | $826.7K |
| Feb 28, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 500 | $206.7K |
| Feb 26, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,000 | $413.3K |
| Feb 12, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 500 | $206.7K |
| Jan 4, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 135 | n/a |